Clinical Research Agreement Template for the United States

A Clinical Research Agreement is a comprehensive legal contract that governs the conduct of clinical trials and research studies involving human subjects in the United States. This document establishes the formal relationship between research sponsors, institutions, and investigators while ensuring compliance with complex federal regulations governing clinical research.

When do you need this document?

You need a Clinical Research Agreement whenever you're planning to conduct clinical trials or research studies involving human subjects. This includes pharmaceutical companies testing new drugs, medical device manufacturers conducting safety studies, academic institutions performing clinical research, or contract research organizations managing multi-site trials. The agreement is essential when multiple parties collaborate on research projects, whether you're a sponsor funding the research, an institution providing facilities and subjects, or a principal investigator leading the study. It's also required when research involves investigational products regulated by the FDA or when studies must comply with Good Clinical Practice standards.

Key legal considerations

Your Clinical Research Agreement must address several critical legal elements to protect all parties and ensure regulatory compliance. The scope of work section should clearly define study objectives, timelines, and deliverables, while compliance provisions must reference adherence to FDA regulations, GCP guidelines, and IRB oversight requirements. Financial terms including payment schedules, budget allocation, and cost responsibilities need careful drafting to avoid disputes. Intellectual property clauses should specify ownership of study data, inventions, and publications arising from the research. Indemnification provisions protect parties from liability related to protocol violations or adverse events. Confidentiality and data protection clauses ensure compliance with HIPAA privacy requirements and protect proprietary information. The agreement should also address termination procedures, audit rights, and regulatory reporting obligations.

Legal requirements in United States

Clinical Research Agreements in the United States must comply with extensive federal regulations governing clinical research. The Federal Food, Drug, and Cosmetic Act provides the primary regulatory framework, while 21 CFR Parts 50, 56, 312, and 54 establish specific requirements for human subject protection, IRB oversight, investigational drug applications, and financial disclosure. The Common Rule (45 CFR Part 46) mandates additional human subjects protections for federally funded research. Your agreement must ensure IRB approval before study initiation, proper informed consent procedures, and adverse event reporting to regulatory authorities. HIPAA Privacy Rule compliance is mandatory when handling protected health information. State laws may impose additional requirements for research conducted within specific jurisdictions, including professional licensing requirements for investigators and institutional oversight obligations.